Shwe Gyaw
About Shwe Gyaw
Shwe Gyaw is a Medical Officer at the National Institutes of Health, specializing in pharmacotherapies and medical consequences, with extensive experience in clinical trials and drug evaluation. He has previously held positions at PAREXEL and Pfizer, and he supports various scientific and project management functions within the NIH.
Work at National Institutes of Health
Currently, Shwe Gyaw serves as a Medical Officer in the Division of Pharmacotherapies and Medical Consequences at the National Institutes of Health (NIH). Since 2011, he has been involved in supporting NIH-sponsored clinical trials, particularly in the evaluation of drug abuse treatment agents. His role includes providing guidance to investigators and ensuring the scientific rigor of clinical evaluations. Gyaw's work focuses on various aspects of clinical trial methodology, including thorough QT studies and dose titration.
Previous Experience at PAREXEL and Pfizer
Prior to his current role at NIH, Shwe Gyaw held the position of Medical Director at PAREXEL from 2006 to 2011. His responsibilities included overseeing clinical trial methodologies and supporting scientific affairs. Additionally, he worked as Associate Director at Pfizer from 2004 to 2006, where he contributed to the development of clinical strategies and medication projects. His experience in these roles has equipped him with a comprehensive understanding of the pharmaceutical industry and clinical research.
Education and Expertise
Shwe Gyaw earned his Bachelor of Medicine, Bachelor of Surgery (M.B.B.S.) from the Institute of Medicine in Yangon, Myanmar, from 1980 to 1985. He furthered his education by obtaining a Master of Science (M.Sc.) in Occupational Medicine from the National University of Singapore in 1991. His educational background supports his extensive expertise in conducting complex phase I and phase II clinical trials, particularly those involving monoclonal antibodies and biologics.
Clinical Research Contributions
Shwe Gyaw has significant experience in conducting various clinical studies, including drug-drug interaction studies, bioavailability/bioequivalence studies, and food effects studies. His involvement in thorough QT studies and dose-ranging studies has contributed to proof of concept studies in drug development. Gyaw collaborates with pharmaceutical companies, academic institutions, and government agencies, including the FDA and Veterans Affairs, to advance medication development projects.
Support for Scientific Affairs and Project Management
In his role at NIH, Shwe Gyaw supports various functions including scientific affairs, project management, data management, quality management, budget and finance, and business development. His comprehensive skill set enables him to effectively manage and oversee clinical trials while ensuring compliance with regulatory standards. Gyaw's contributions to these areas enhance the overall efficiency and effectiveness of clinical research initiatives.